Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: subgroup analysis of the phase IIIb CompLEEment-1 trial
Titel:
Ribociclib plus letrozole in male patients with hormone receptor-positive, human epidermal growth factor receptor 2-negative advanced breast cancer: subgroup analysis of the phase IIIb CompLEEment-1 trial
Auteur:
Campone, Mario De Laurentiis, Michelino Zamagni, Claudio Kudryavcev, Igor Agterof, Mariëtte Brown-Glaberman, Ursa Palácová, Markéta Chatterjee, Sanjoy Menon-Singh, Lakshmi Wu, Jiwen Martín, Miguel